Silence Therapeutics (SLN) Exchange Rate Effect (2020 - 2026)
Silence Therapeutics recorded quarterly Exchange Rate Effect of -$17000.0 in Q1 2026, up 86.82% quarter-over-quarter from -$129000.0 in Q4 2025, and down 107.33% year-over-year from $232000.0 in Q1 2025.
Silence Therapeutics' Exchange Rate Effect history runs 7 years deep, the most recent figure standing at -$17000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 107.33% year-over-year to -$17000.0; the TTM figure through Mar 2026 stood at -$54000.0 (up 99.18% YoY), while the FY2025 annual figure was $195000.0, up 225.0% from the prior year.
- Exchange Rate Effect came in at -$17000.0 for Q1 2026 at Silence Therapeutics, up from -$129000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $5.7 million in Q3 2022 to a low of -$6.5 million in Q3 2024.
- A 5-year average of -$589973.2 and a median of -$106000.0 in 2025 frame the typical range for Exchange Rate Effect.
- On a YoY basis, Exchange Rate Effect climbed as much as 6789.05% in 2022 and fell as far as 2536.12% in 2022.
- Silence Therapeutics' Exchange Rate Effect stood at -$6.4 million in 2022, then soared by 37.23% to -$4.0 million in 2023, then jumped by 96.02% to -$159000.0 in 2024, then increased by 18.87% to -$129000.0 in 2025, then soared by 86.82% to -$17000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered -$17000.0, -$129000.0, and -$106000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 | -17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17,000.00 |
| Mar 31, 2026 | -17,000.00 |
| Dec 31, 2025 | -129,000.00 |
| Dec 31, 2025 | -129,000.00 |
| Sep 30, 2025 | -106,000.00 |
| Sep 30, 2025 | -106,000.00 |
| Jun 30, 2025 | 198,000.00 |
| Jun 30, 2025 | 198,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Dec 31, 2024 | -159,000.00 |
| Dec 31, 2024 | -159,000.00 |
| Sep 30, 2024 | -6.50 Mn |
| Sep 30, 2024 | -6.50 Mn |
| Jun 30, 2024 | -195,644.22 |
| Jun 30, 2024 | -195,644.22 |
| Mar 31, 2024 | -35,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Dec 31, 2023 | -3.99 Mn |
| Dec 31, 2023 | -3.99 Mn |
| Sep 30, 2023 | 1.65 Mn |
| Sep 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | -664,473.83 |
| Jun 30, 2023 | -664,473.83 |
| Mar 31, 2023 | -700,133.48 |
| Mar 31, 2023 | -700,133.48 |
| Dec 31, 2022 | -6.36 Mn |
| Dec 31, 2022 | -6.36 Mn |
| Sep 30, 2022 | 5.70 Mn |
| Sep 30, 2022 | 5.70 Mn |
| Jun 30, 2022 | 735,439.50 |
| Jun 30, 2022 | 735,439.50 |
| Mar 31, 2022 | 311,305.88 |
| Mar 31, 2022 | 311,305.88 |
| Dec 31, 2021 | -241,293.90 |
| Dec 31, 2021 | -241,293.90 |
| Sep 30, 2021 | 82,715.00 |
| Sep 30, 2021 | 82,715.00 |
| Jun 30, 2021 | -29,352.29 |
| Jun 30, 2021 | -29,352.29 |
| Mar 31, 2021 | 48,262.23 |
| Mar 31, 2021 | 48,262.23 |
| Dec 31, 2020 | -1.22 Mn |
| Dec 31, 2020 | -1.22 Mn |
| Sep 30, 2020 | -264,553.07 |
| Sep 30, 2020 | -264,553.07 |